UPDATE : Friday, September 20, 2019
상단여백
GC Labcell releases pre-clinical trial results for NK cell treatment by Lee Han-soo 2019-07-18 14:22
Sanofi vaccinates Gwangju FINA Championships staffs against hepatitis A by Lee Han-soo 2019-07-18 10:49
CrystalGenomics’ US partner starts injecting leukemia treatment candidate by Lee Han-soo 2019-07-17 17:45
‘RIGHT Fund aims to use Korean innovation for global health equity’ by Lee Han-soo 2019-07-17 17:41
Korean, Japanese healthcare firms reaffirm ‘joint growth’ amid trade feud by Jeong Sae-im 2019-07-17 14:06
라인
RIGHT Fund reveals 1st investment into public health projects in developing countries by Lee Han-soo 2019-07-17 14:03
'Biktarvy -- a pill a day to treat HIV' by Lee Han-soo 2019-07-17 10:09
Ono Pharma Korea names new CEO by Lee Han-soo 2019-07-16 11:24
Daewoong, Medytox differ in interpreting US trade agency’s order by Lee Han-soo 2019-07-15 17:44
Self-claimed Korea Otsuka employee causes stir on far-right website by Lee Han-soo 2019-07-15 15:57
라인
China OKs Huonland's hyaluronic acid eye drop by Lee Han-soo 2019-07-15 13:57
Japanese pharma companies closely following 'Boycott Japan' campaign by Lee Han-soo 2019-07-12 17:07
Daewoong to co-promote Lundbeck Korea's Alzheimer's disease treatment by Lee Han-soo 2019-07-12 15:13
Regulator OKs Merck Korea's relapsing-remitting multiple sclerosis treatment by Lee Han-soo 2019-07-11 17:39
Humira permitted for nursing, pregnant patients by Kim Yun-mi 2019-07-11 16:41
라인
SCM Life Science, MitoImmune Therapeutics to develop new treatment by Lee Han-soo 2019-07-11 16:40
Acute renal failure reported in ibandronate injections by Lee Hye-seon 2019-07-11 13:34
Yuyu holds 3rd annual compliance program workshop by Lee Han-soo 2019-07-11 12:09
Contera Pharma gets ₩3 billion funding from venture capital by Jeong Sae-im 2019-07-10 17:28
Court to test Nabota’s spore-forming to end Daewoong-Medytoxin dispute by Jeong Sae-im 2019-07-10 12:44
여백
여백
여백
Back to Top